Type-1 University logo
arrow-icon-size3 Back to all courses

GLP-1s & T1D:  The Real Story

Living with T1D is tough enough without the constant hunger and weight gain that is becoming increasingly common.  GLP-1 receptor agonists (and GIP) represent a class of medications that are approved and effective for both diabetes management and weight loss, but come with multiple challenges when used by people with Type-1 Diabetes. This course covers the physiologic impact of these medications and strategies for maximizing benefits while minimizing risks. Specific topics include: 

  • The challenges of living with T1D
  • GLP-1 mechanisms of action
  • Research outcomes
  • Medication options
  • Side effects and safety strategies
  • Navigating insurance coverage
  • Next steps and resources

Not sure you need this course?

Take the 5-question “placement exam” and find out!
Start Exam
no pressure!

Placement Exam: GLP-1s & T1D

1. What percentage of adults with T1D is considered overweight or obese?

A. 10-20%
B. 30-40%
C. 50-60%
D. More than 60%

2. GLP-1 medications affect which organs of the body?

A. Liver, pancreas and kidneys
B. Stomach, brain and pancreas
C. Muscle, stomach and intestines
D. Muscle, brain and liver

3. How often are most GLP-1 medications taken?

A. Once daily
B. Twice daily
C. Once weekly
D. Once monthly

Close

4. What effect does GLP-1 tend to have on insulin requirements once an effective dose is reached?

A. Bolus doses decrease, but basal needs stay about the same
B. Basal needs decrease, but bolus doses stay about the same
C. Both basal and bolus doses tend to decrease
D. Both basal and bolus doses tend to increase

5. When discussing use of a GLP-1 with your healthcare provider, it is important to:

A. Take a strong and forceful approach (don’t take no for an answer!)
B. Let them know that you will take full responsibility for whatever happens
C. Come prepared with details about potential benefits and side effects
D. Ask for a referral to someone who is comfortable prescribing GLP-1s

Answers: D,B,C,C,C